FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Valneva Chikungunya OK to Use Again: FDA

[ Price : $8.95]

FDA lifts an earlier recommended pause on the use of Valnevas Ixchiq vaccine for chikungunya virus.

FDA Steps to Boost U.S. Drug Production

[ Price : $8.95]

FDA says it is starting the FDA PreCheck program to help drug companies develop manufacturing facilities in the U.S.

ICH Extractables, Leachables Guide

[ Price : $8.95]

FDA publishes a draft International Council on Harmonization guideline for extractables and leachables to solicit public comment.

Julie Tierney Joins Leavitt Partners

[ Price : $8.95]

Former FDAer Julie Tierney is now a principal in Leavitt Partners Washington office.

J&J Complete Response Letter on Darzalex Faspro

[ Price : $8.95]

FDA issues Johnson & Johnson a complete response letter for its supplemental BLA for Darzalex Faspro (daratumumab and hyaluronidas...

Instylla PMA Approved for Hypervascular Tumors

[ Price : $8.95]

FDA approves an Instylla PMA for its Embrace Hydrogel Embolic System, a liquid embolic device for treating hypervascular tumors in...

FDA Acting Against Unapproved Thyroid Meds

[ Price : $8.95]

FDA says it will allow up to 12 months for doctors to transition patients who are taking unapproved animal-derived thyroid medicat...

Lilly Plans NDA for Oral Weight-Loss Drug

[ Price : $8.95]

Eli Lilly says it will file an NDA by the end of the year for its investigational obesity treatment orforglipron, based on just-an...

Alert on Boston Scientific Defibrillation Leads

[ Price : $8.95]

FDA issues an early alert based on a Boston Scientific letter to customers about certain Endotak Reliance defibrillation leads tha...

FDA Early Alert on Watchman Devices

[ Price : $8.95]

FDA issues an alert after Boston Scientific notified customers that all lots of certain Watchman Access Systems have updated use i...